SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-009093
Filing Date
2021-05-05
Accepted
2021-05-05 16:17:36
Documents
16
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arna-20210505.htm   iXBRL 8-K 38343
2 EX-99.1 arna-20210505xexx991pressr.htm EX-99.1 74253
8 image_01a.jpg GRAPHIC 8392
  Complete submission text file 0001628280-21-009093.txt   279894

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arna-20210505.xsd EX-101.SCH 2429
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arna-20210505_cal.xml EX-101.CAL 714
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arna-20210505_def.xml EX-101.DEF 1647
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arna-20210505_lab.xml EX-101.LAB 24993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arna-20210505_pre.xml EX-101.PRE 13194
9 EXTRACTED XBRL INSTANCE DOCUMENT arna-20210505_htm.xml XML 11920
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 21893556
SIC: 2834 Pharmaceutical Preparations